Differences in time to patient access to innovative cancer medicines in six European countries
Differences in time to patient access to innovative cancer medicines in six European countries is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Differences in time to patient access to innovative cancer medicines in six European countries have?
Differences in time to patient access to innovative cancer medicines in six European countries has 22 citations in the OpenAlex counts ScholarIQ stores.
When was Differences in time to patient access to innovative cancer medicines in six European countries published?
Differences in time to patient access to innovative cancer medicines in six European countries has 2023 year in the ScholarIQ index.
What is the open-access status of Differences in time to patient access to innovative cancer medicines in six European countries?
Differences in time to patient access to innovative cancer medicines in six European countries has hybrid oa status in the ScholarIQ index.
What is the DOI of Differences in time to patient access to innovative cancer medicines in six European countries?
The DOI for Differences in time to patient access to innovative cancer medicines in six European countries is on the source record.
What is the PMID of Differences in time to patient access to innovative cancer medicines in six European countries?
The PMID for Differences in time to patient access to innovative cancer medicines in six European countries is on the source record.
What is the OpenAlex record for Differences in time to patient access to innovative cancer medicines in six European countries?
The OpenAlex for Differences in time to patient access to innovative cancer medicines in six European countries is on the source record.